Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Viruses|September 28, 2024
The Omicron Variant Is Associated with a Reduced Risk of the Post COVID-19 Condition and Its Main Phenotypes Compared to the Wild-Type Virus: Results from the EuCARE-POSTCOVID-19 StudyFrancesca Bai, Andrea Santoro, Pontus Hedberg, et al.
BMC Infectious Diseases|April 29, 2025
Short and long-term trajectories of the post COVID-19 condition: Results from the EuCARE POSTCOVID studyAndrea Santoro, Francesca Bai, Maria Francesca Greco, et al.
Life (Basel, Switzerland)|September 28, 2021
Declining Mortality Rate of Hospitalised Patients in the Second Wave of the COVID-19 Epidemics in Italy: Risk Factors and the Age-Specific PatternsAntonella D'Arminio Monforte, Alessandro Tavelli, Francesca Bai, et al.
Frontiers in Medicine|March 26, 2024
Development and validation of a prediction score for failure to casirivimab/imdevimab in hospitalized patients with COVID-19 pneumoniaAlessandro Cozzi-Lepri, Vanni Borghi, Salvatore Rotundo, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 11, 2024
Learning from post-COVID-19 condition for epidemic preparedness: a variable catalogue for future post-acute infection syndromesAnna Górska, Lorenzo Maria Canziani, Eugenia Rinaldi, et al.
Plos One|November 19, 2013
Maraviroc as intensification strategy in HIV-1 positive patients with deficient immunological response: an Italian randomized clinical trialStefano Rusconi, Paola Vitiello, Fulvio Adorni, et al.
Vaccines|November 25, 2023
SARS-CoV-2 mRNA Vaccine Response in People Living with HIV According to CD4 Count and CD4/CD8 RatioAlessandra Vergori, Alessandro Tavelli, Giulia Matusali, et al.
Eclinicalmedicine|March 20, 2023
Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study)Ilaria Mastrorosa, Roberta Gagliardini, Francesco Vladimiro Segala, et al.
Heliyon|September 9, 2024
Monoclonal antibodies against SARS-CoV-2 to prevent COVID-19 worsening in a large multicenter cohortAlessandro Soria, Francesca Graziano, Giulia Ghilardi, et al.
Pageof 6